Access cutting-edge diabetic macular edema treatment through this clinical trial at a research site in Encino. Study-provided care at no cost to qualified participants.
Access diabetic macular edema specialists in Encino at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diabetic macular edema treatment provided free
This study aims to evaluate the ocular and systemic safety, tolerability and efficacy of RO7446603 in participants with diabetic macular edema (DME). The study consists of 2 segments: Phase I (Parts 1-4) and Phase II (Part 5). Phase I investigated the safety of RO7446603 following a single and multiple intravitreal (IVT) doses as monotherapy or co-administered with IVT aflibercept or IVT faricimab (in separate injections). Phase II will investigate the safety, tolerability, pharmacokinetics (PK)
Sponsor: Genentech, Inc.
Check if you qualify for this diabetic macular edema clinical trial in Encino, CA
If you're searching for diabetic macular edema treatment options in Encino, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encino research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.